DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Centers for Disease Contol.
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Morb Mortal Wkly Rep 2013;
62: 521-524
Access:
We do not assume any responsibility for the contents of the web pages of other providers.